Literature DB >> 33420819

Generic rocuronium reduces withdrawal movements compared to original rocuronium under target-controlled infusion induction with propofol.

Kosuke Hamada1, Kazunobu Takahashi2, Yasuyuki Tokinaga1, Soshi Iwasaki1, Michiaki Yamakage1.   

Abstract

PURPOSE: Rocuronium-induced injection pain often causes withdrawal movements leading to accidental disruption of indwelling needles. Generic rocuronium (Maruishi Pharmaceutical Co., Ltd, Osaka, Japan) with a novel solution has been reported to reduce the injection pain compared to original rocuronium [Esmeron® (Eslax®), MSD Co. Ltd, Tokyo, Japan], however, no reports have compared the injection pain under sedation with propofol, the most frequently used general anesthetic. This study was carried out to compare the injection pain caused by generic rocuronium and that caused by original rocuronium in patients anesthetized by propofol with a target-controlled infusion system.
METHODS: Forty patients were randomly assigned to two groups in this single-center, prospective, randomized, double-blind study. One group was administered generic rocuronium after sedation with propofol with a target-controlled infusion system. The other group was administered original rocuronium after anesthesia with propofol. Patient's withdrawal movements were assessed with the scale. The primary outcome was the total incidence of movement after administration of rocuronium. Secondary outcome was the incidence of moderate or severe movement after administration of rocuronium.
RESULTS: The total incidence of movement after administration of generic rocuronium (11%) was significantly lower than that after the administration of original rocuronium (79%) (p < 0.01). The incidence of moderate or severe movement after administration of generic rocuronium (0%) was significantly lower than that after the administration of original rocuronium (53%) (p < 0.01).
CONCLUSION: Generic rocuronium was considered more suitable than the original rocuronium for induction of anesthesia by propofol performed with a target-controlled infusion system.

Entities:  

Keywords:  Injection pain; Propofol; Rocuronium; Target-controlled infusion; Withdrawal movements

Mesh:

Substances:

Year:  2021        PMID: 33420819     DOI: 10.1007/s00540-020-02889-2

Source DB:  PubMed          Journal:  J Anesth        ISSN: 0913-8668            Impact factor:   2.078


  28 in total

1.  Current practice of rapid sequence induction of anaesthesia in the UK - a national survey.

Authors:  A Sajayan; J Wicker; N Ungureanu; C Mendonca; P K Kimani
Journal:  Br J Anaesth       Date:  2016-02-24       Impact factor: 9.166

2.  Pain on injection of rocuronium bromide.

Authors:  S S Moorthy; S F Dierdorf
Journal:  Anesth Analg       Date:  1995-05       Impact factor: 5.108

3.  The use of lidocaine for preventing the withdrawal associated with the injection of rocuronium in children and adolescents.

Authors:  Y Shevchenko; J C Jocson; V A McRae; S A Stayer; R E Schwartz; M Rehman; D K Choudhry
Journal:  Anesth Analg       Date:  1999-04       Impact factor: 5.108

4.  Spontaneous movements associated with rocuronium: is pain on injection the cause?

Authors:  A Borgeat; D Kwiatkowski
Journal:  Br J Anaesth       Date:  1997-09       Impact factor: 9.166

5.  Prevention of rocuronium injection pain.

Authors:  Sungsik Park
Journal:  Korean J Anesthesiol       Date:  2014-12

6.  Dilution of rocuronium to 0.5 mg/mL with 0.9% NaCl eliminates the pain during intravenous injection in awake patients.

Authors:  Bahattin Tuncali; Ayse Karci; Binnur Erdalkiran Tuncali; Omur Mavioglu; Cimen Gulben Olguner; Selin Ayhan; Zahide Elar
Journal:  Anesth Analg       Date:  2004-09       Impact factor: 5.108

7.  Neutralized rocuronium (pH 7.4) before administration prevents injection pain in awake patients: a randomized prospective trial.

Authors:  Dong Woo Han; Bon Nyeo Koo; Seung Ho Choi; Jong Seok Lee; Yang Sik Shin; Manohar Sharma; Ki Jun Kim
Journal:  J Clin Anesth       Date:  2007-09       Impact factor: 9.452

Review 8.  Pain on injection of propofol.

Authors:  C H Tan; M K Onsiong
Journal:  Anaesthesia       Date:  1998-05       Impact factor: 6.955

Review 9.  Pharmacological prevention of rocuronium-induced injection pain or withdrawal movements: a meta-analysis.

Authors:  Hyun Jeong Kwak; Ji Young Kim; Yong Beom Kim; Sang Kee Min; Bong Ki Moon; Jong Yeop Kim
Journal:  J Anesth       Date:  2013-03-22       Impact factor: 2.078

10.  Single pretreatment of remifentanil may reduce pain after propofol and rocuronium injection in rapid sequence induction.

Authors:  Yoon Ji Choi; Han Seok Park; Han Lee; Seung Zhoo Yoon
Journal:  Korean J Anesthesiol       Date:  2012-11-16
View more
  1 in total

1.  Time interval between alfentanil and rocuronium administration necessary to prevent rocuronium-induced withdrawal movement.

Authors:  Xiao-Dan Wang; Ling-Yang Chen; Chun-Lian Zhou; Hai-Tao Cong; Nan-Jin Chen; Ming-Cang Wang
Journal:  BMC Anesthesiol       Date:  2022-02-01       Impact factor: 2.217

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.